Since its foundation in 1991, Mindray has been exclusively focused on the medical industry in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging. Headquartered in Shenzhen China, Mindray is a multinational corporation with subsidiaries in 31 countries in North and South America, Europe, Africa, and the Asia-Pacific region. The company’s products and services can be found in healthcare facilities in over 190 countries. Driven by innovation, Mindray has built up a global R&D network with 10 research centers in the US, Europe, and China. Focused on fully understanding the needs of both patients and practitioners, Mindray’s insightful innovation produces ergonomically optimized medical devices that are readily accessible by the healthcare practitioner, allowing doctors and nurses to focus on the patient, not the machine. Mindray closely controls all aspects of R&D and production, from design through to manufacturing of the final product. An integrated in-house production facility ensures the highest quality and also reduces costs, maximizing value for customers and ultimately making healthcare accessible to more people. Mindray Medical International Ltd acquired Ulco Medical Pty. (“Ulco”), Mindray’s former distributor, based in Australia in September of 2013. Subsequently Ulco became known as Mindray Medical Australia Pty. As a result of the acquisition Mindray has gained access to MMA’s established sales and services capabilities in the Oceania region and the 50 years of experience the company has in the market. Mindray is leveraging its global platform to support MMA’s future development in the region. MMA has already taken on the Infusion & Syringe Pumps and Surgical product lines as well as Ultrasounds of Mindray to complement their extensive offering in Patient Monitoring & Life Support (PMLS) systems to now be able to offer a complete solution (One Solution).
